Lupin has received tentative approval from the USFDA to market a generic HIV drug in the US under PEPFAR. The drug, made at ...
This new generic medicine is designed to be a simple, once-daily treatment for children as young as three months old who ...
Drug firm Lupin on Friday said it has received approval from the US health regulator to market a generic HIV medication in ...
The US Food and Drug Administration (FDA) has approved the abbreviated new drug application (ANDA) of Lupin’s Sacubitril and ...
Lupin receives US FDA marketing nod for generic Triumeq PD tablets for oral suspension to trteat HIV-1 infection: Our Bureau, Mumbai Friday, January 24, 2025, 14:15 Hrs [IST] Glob ...
Lupin API Plus SBU head ... tablets enables us to improve the well-being of paediatric patients with HIV-1, thereby significantly boosting our HIV medication portfolio.” In September 2024 ...
Mirroring the Sensex, NSE Nifty50 also ended lower by 113.15 points or 0.49 per cent at 23,092.20. The Nifty50 recorded a day ...